Stay updated on AbbVie Press Releases

Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the AbbVie Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    The news feed now features October announcements, including a federal 340B pilot, RINVOQ vitiligo data, and an upcoming earnings call, alongside new research and company updates. Older September headlines and social posts have been replaced by more recent content.
    Difference
    10%
    Check dated 2026-10-03T14:06:58.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The News Center gained new posts on September 22, 2026, including AbbVie’s participation in a USTR investigation, Allergan Aesthetics’ AA Signature launch with SKIN360, and European Commission approval of Rinvoq for pediatric JIA, while several older Real-world Data/IMS-related items were removed, indicating a feed refresh and content cleanup.
    Difference
    11%
    Check dated 2026-09-26T15:57:23.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    New News Center items were added, including real-world data on VRAYLAR at Psych Congress 2026, Phase 3 etentamig results for multiple myeloma at the IMS meeting, and Allergan Aesthetics data. Older posts and content blocks were removed, refining the lineup of featured news on the page.
    Difference
    10%
    Check dated 2026-09-19T22:05:20.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    New September 2026 news entries have been added to the News Center, including the AbbVie Declares Quarterly Dividend and Atogepant Phase 3 results, with related links. Some older items have been removed from the listing.
    Difference
    10%
    Check dated 2026-09-12T20:57:46.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    New News Center items have been added, including topline results from the CERVINO trial, the Apogee Therapeutics acquisition, and a Morgan Stanley conference presentation, along with related social excerpts. Older, non-essential links and tags were removed to streamline the feed and focus on current announcements.
    Difference
    10%
    Check dated 2026-09-05T20:13:29.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Adds an August 27, 2026 news item announcing AbbVie’s EMA regulatory submission for SKYRIZI subcutaneous induction in adults with Crohn’s disease, along with related social posts and quick links. Also removes several older updates (e.g., Allergan Aesthetics privileges news and the Q2 2026 financial results post), altering the page’s current lineup of stories.
    Difference
    7%
    Check dated 2026-08-29T21:54:28.000Z thumbnail image

Stay in the know with updates to AbbVie Press Releases

Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.